Creative Planning
INBX icon

Creative Planning’s Inhibrx INBX Stock Holding History

Creative Planning’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$445K Buy
6,618
+910
+16% +$67.5K ﹤0.01% 3114
2025
Q4 		$451K Buy
+5,708
New +$389K ﹤0.01% 2931
2025
Q1 		– Sell
-222
Closed -$3.42K – 3596
2024
Q4 		$3.42K Buy
+222
New +$3.38K ﹤0.01% 3430

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Creative Planning's INBX Position: Q1 2026 in Review

Creative Planning increased its Inhibrx (INBX) stake by 16% in Q1 2026, buying an estimated $67.5K and bringing the position to 6,618 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

Creative Planning first reported a position in INBX in Q4 2024 and has held it in 3 quarters since. The position peaked at $451K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Creative Planning held 6,618 shares of Inhibrx worth $445K as of Q1 2026.
  • Creative Planning bought 910 Inhibrx shares in Q1 2026, an estimated $67.5K.
  • Inhibrx made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3114 holding.
  • Creative Planning first reported a position in Inhibrx in Q4 2024 and has held it in 3 quarters since.
  • Creative Planning's Inhibrx position peaked at $451K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.